Addus HomeCare (NASDAQ:ADUS) Stock Rating Upgraded by Wall Street Zen

Addus HomeCare (NASDAQ:ADUS) was upgraded by research analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report issued on Saturday.

Other research analysts have also recently issued research reports about the stock. Cowen reissued a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th. Barclays upped their price objective on shares of Addus HomeCare from $111.00 to $117.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 4th. Royal Bank Of Canada raised their target price on shares of Addus HomeCare from $134.00 to $139.00 and gave the company an “outperform” rating in a research report on Friday, November 7th. Truist Financial set a $135.00 target price on shares of Addus HomeCare and gave the stock a “buy” rating in a research note on Wednesday, January 7th. Finally, TD Cowen increased their price target on Addus HomeCare from $139.00 to $140.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Addus HomeCare presently has an average rating of “Moderate Buy” and a consensus target price of $136.90.

Addus HomeCare Trading Down 2.1%

Shares of ADUS stock opened at $107.50 on Friday. The stock’s fifty day moving average price is $112.52 and its two-hundred day moving average price is $113.27. The company has a market cap of $1.99 billion, a PE ratio of 23.02, a P/E/G ratio of 1.29 and a beta of 0.92. Addus HomeCare has a fifty-two week low of $88.96 and a fifty-two week high of $136.72. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.66 and a current ratio of 1.66.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, November 3rd. The company reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.53 by $0.03. The company had revenue of $362.30 million during the quarter, compared to analysts’ expectations of $354.48 million. Addus HomeCare had a return on equity of 9.53% and a net margin of 6.36%.Addus HomeCare’s revenue was up 25.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.30 EPS. Equities analysts predict that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Insider Activity at Addus HomeCare

In related news, EVP Darby Anderson sold 20,000 shares of the business’s stock in a transaction on Wednesday, November 19th. The shares were sold at an average price of $109.00, for a total value of $2,180,000.00. Following the sale, the executive vice president owned 44,144 shares of the company’s stock, valued at $4,811,696. The trade was a 31.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders have sold a total of 20,316 shares of company stock worth $2,215,998 in the last quarter. 4.50% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Royal Bank of Canada increased its stake in shares of Addus HomeCare by 24.3% in the first quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock valued at $682,000 after buying an additional 1,347 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Addus HomeCare by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock valued at $1,026,000 after purchasing an additional 459 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Addus HomeCare by 6.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock worth $5,111,000 after purchasing an additional 2,952 shares during the last quarter. Jane Street Group LLC lifted its position in shares of Addus HomeCare by 387.6% in the 1st quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock worth $1,092,000 after purchasing an additional 8,780 shares during the period. Finally, Intech Investment Management LLC lifted its position in shares of Addus HomeCare by 44.7% in the 1st quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock worth $1,420,000 after purchasing an additional 4,439 shares during the period. 95.35% of the stock is owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.